Schizophrenia is a serious and chronic brain disorder that affects a person’s ability to think clearly, manage emotions, make ...

“Schizophrenia can affect this ability, leading to misinterpretations of others' intentions or difficulties in managing social interactions,” he says. “Executive functions refer to a set of ...

At the Institute of Mental Health (IMH), almost 60 per cent to 70 per cent of patients with schizophrenia make a good ...

Scientists at Stanford Medicine are advancing the understanding of schizophrenia by creating a "periodic table" for ...

Researchers from Singapore's National Healthcare Group (NHG)'s Institute of Mental Health (IMH) and Agency for Science, ...

As a result of the disappointing results, Boehringer said that it was abandoning a long-term extension trial called CONNEX-X, ...

Characterised by significant impairments in perception and changes in behaviour, schizophrenia affects approximately 24 ...

The global schizophrenia drugs market size was valued at USD 7.88 billion in 2024 and is projected to reach from USD 8.28 ...

Research suggests a link between schizophrenia and changes in the immune system, highlighting potential new pathways for ...

This new finding could help explain why some children develop neurodevelopmental disorders, such as autism or schizophrenia.

Boehringer Ingelheim announced that its schizophrenia drug, iclepertin, did not achieve statistically significant ...

Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with ...